MATERNAL SERUM SCREEN 3 TRIPLE Test
Test Cost: AED 630.0
Test Components:
- AFP
- Beta HCG
- Free Estriol
- Risk Evaluation
Sample Condition:
3 mL (1.5 mL min.) serum from 1 SST. Ship refrigerated or frozen. Provide maternal Date of birth (dd/mm/yy); LMP or Ultrasound; IVF, Number of Fetuses (Single/Twins); Diabetic status and Body Weight in Kg, Smoking & Previous history of Trisomy 21 pregnancy. Duly filled Maternal Serum Screen requisition form (Form 11) is mandatory. Valid between 14-22 weeks gestation (Ideal 15-20 weeks).
Report Delivery:
Sample Mon through Sat by 9 am; Report Same day
Method:
Chemiluminescent Immunoassay
Test Type:
Prenatal Diagnosis
Doctor:
Gynecologist
Test Department:
Pre Test Information
Provide maternal Date of birth (dd/mm/yy); LMP or Ultrasound; IVF, Number of Fetuses (Single/Twins); Diabetic status and Body Weight in Kg, Smoking & Previous history of Trisomy 21 pregnancy. Duly filled Maternal Serum Screen requisition form (Form 11) is mandatory. Valid between 14-22 weeks gestation (Ideal 15-20 weeks).
Test Details:
The Maternal Serum Screen 3 Triple Test is a prenatal screening test that measures the levels of three specific substances in a pregnant woman’s blood: alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), and estriol. This test is typically performed between 15 and 20 weeks of pregnancy and is used to assess the risk of certain chromosomal abnormalities, such as Down syndrome, trisomy 18, and neural tube defects. The results of the test are combined with the woman’s age, gestational age, and other factors to calculate the risk of these abnormalities. However, it is important to note that this test is not diagnostic, meaning it cannot provide a definitive diagnosis of these conditions. If the test results indicate a higher risk, further diagnostic tests, such as amniocentesis or chorionic villus sampling, may be recommended to confirm the presence of a chromosomal abnormality.
| Test Name | MATERNAL SERUM SCREEN 3 TRIPLE Test Test |
|---|---|
| Components | *AFP*Beta HCG*Free Estriol*Risk Evaluation |
| Price | 630.0 AED |
| Sample Condition | 3 mL (1.5 mL min.) serum from 1 SST. Ship refrigerated or frozen. Provide maternal Date of birth (dd\/mm\/yy); LMP or Ultrasound; IVF, Number of Fetuses (Single\/ Twins); Diabetic status and Body Weight in Kg, Smoking &\nPrevious history of Trisomy 21 pregnancy. Duly filled Maternal Serum Screen requisitionform (Form 11) is mandatory. Valid between 14-22 weeks gestation (Ideal 15-20 weeks). |
| Report Delivery | Sample Mon through Sat by 9 am; Report Same day |
| Method | Chemiluminescent Immunoassay |
| Test type | Prenatal Diagnosis |
| Doctor | Gynecologist |
| Test Department: | |
| Pre Test Information | Provide maternal Date of birth (dd/mm/yy); LMP or Ultrasound; IVF, Number of Fetuses (Single/ Twins); Diabetic status and Body Weight in Kg, Smoking & Previous history of Trisomy 21 pregnancy. Duly filled Maternal Serum Screen requisitionform (Form 11) is mandatory. Valid between 14-22 weeks gestation (Ideal 15-20 weeks). |
| Test Details |
The Maternal Serum Screen 3 Triple Test is a prenatal screening test that measures the levels of three specific substances in a pregnant woman’s blood: alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), and estriol. This test is typically performed between 15 and 20 weeks of pregnancy and is used to assess the risk of certain chromosomal abnormalities, such as Down syndrome, trisomy 18, and neural tube defects. The results of the test are combined with the woman’s age, gestational age, and other factors to calculate the risk of these abnormalities. However, it is important to note that this test is not diagnostic, meaning it cannot provide a definitive diagnosis of these conditions. If the test results indicate a higher risk, further diagnostic tests, such as amniocentesis or chorionic villus sampling, may be recommended to confirm the presence of a chromosomal abnormality. |
